Combination of hypertension and atrial fibrillation is a ticking time bomb – experts call for simultaneous screening
Reports and Proceedings
In recognition of Heart Health Month, we’re spotlighting the importance of cardiovascular wellness. From risk factors and prevention to innovative treatments, we’re exploring the science and stories shaping heart health today.
Updates every hour. Last Updated: 27-Jul-2025 03:10 ET (27-Jul-2025 07:10 GMT/UTC)
A group of 29 international experts says that simultaneous screening for hypertension and heart arrhythmia could prevent thousands of strokes.
Wearable mobile health technology could help people with Type 2 Diabetes (T2D) to stick to exercise regimes that help them to keep the condition under control, a new study reveals.
An international team publishing in the BMJ Open studied the behaviour of recently-diagnosed T2D patients in Canada and the UK as they followed a home-based physical activity programme, with some participants wearing a smartwatch paired with a health app on their smartphone.
The ‘Mobile Health Biometrics to Enhance Exercise and Physical Activity Adherence in Type 2 Diabetes (MOTIVATE-T2D) feasibility trial recruited participants aged 40-75 years, diagnosed with T2D within the previous 5-24 months and managing their condition through lifestyle modification alone or Metformin.
They discovered that MOTIVATE-T2D participants were more likely to start and maintain purposeful exercise at if they had the support of wearable technology. The study successfully recruited 125 participants with an 82% retention rate after 12 months.